Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ADTX
ADTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ADTX News
Aditxt Inc. (ADTX) Completes Reverse Split, Shares Surge Over 20%
Jan 21 2026
NASDAQ.COM
GameStop Corp (GME) CEO Ryan Cohen Buys 500,000 Shares, Stock Rises 2.6%
Jan 21 2026
Benzinga
Dow Rises by 150 Points as Jabil Reports Positive Earnings
Dec 17 2025
Benzinga
Stock Market Update: S&P 500 and Dow Futures Rise Amid Jobs Data Impact—Focus on Lennar, Micron Technology, and Children's Place
Dec 17 2025
Benzinga
Aditxt Shares Surge Approximately 63%; Check Out 20 Stocks Making Moves in Premarket Trading
Dec 17 2025
Benzinga
What Caused Aditxt (ADTX) Stock to Jump 52% in After-Hours Trading?
Dec 17 2025
Benzinga
Vision Marine Technologies Stock Rises Over 10%; Check Out 20 Stocks Making Moves in Premarket Trading
Dec 01 2025
Benzinga
Stock Splits Scheduled for This Week (November 3 to November 7) – Keep Your Investments Active
Nov 02 2025
TipRanks
Alphabet Shares Rise Approximately 8%; Check Out 20 Stocks Making Moves in Premarket Trading
Oct 30 2025
Benzinga
Intel Shares Rise Approximately 8%; Check Out 20 Stocks Making Moves in Premarket Trading
Oct 24 2025
Benzinga
Evofem Reveals Outcomes of Stockholders' Special Meeting Vote
Oct 20 2025
Newsfilter
Evofem's "Say Vagina" Campaign Achieves Over 2.5 Million Views on Social Media
Sep 11 2025
Newsfilter
Evofem Expects Merger with Aditxt to Be Approved at Upcoming Shareholder Meeting
Sep 09 2025
Newsfilter
Aditxt's Subsidiary Adimune Showcases Its Method for Immune System Reprogramming via DNA Instructions, Boasting 96 Granted and 22 Pending Patents Aimed at the Autoimmunity Market Projected to Exceed $160 Billion by 2030
Aug 25 2025
Newsfilter
Illinois Pharmacists Authorized to Prescribe PHEXXI Beginning January 2026 Following New Legislation
Aug 21 2025
Newsfilter
FDA Orange Book Includes New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Solution for Bacterial Vaginosis and Trichomoniasis
Aug 19 2025
Newsfilter
Show More News
